Christopher E Walsh, MD, PhD

Research

Locations

Department of Medicine - Hematology

5 East 98th Street, 12th Floor, New York, NY, 10029

212-241-8303

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:29

Review Article:10

Comment/Debate:1

Letter:2

Recent Artifacts

• Targeted integration of a rAAV vector into the AAVS1 region
• Safe and sustained overexpression of functional apolipoprotein a-i/high-density lipoprotein in apolipoprotein a-i-null mice by muscular adeno-associated viral serotype 8 vector gene transfer
• Chimeric AAV Cap sequences alter gene transduction
• Factor VIII prophylaxis for adult patients with severe haemophilia A: Results of a US survey of attitudes and practices
• Prophylaxis for adults with severe haemophilia: A compelling need for evidence-based guidelines
• Intrathecal long-term gene expression by self-complementary adeno-associated virus type I suitable for chronic pain studies in rats
• RNA repair for haemophilia A
• Spliceosome-mediated RNA trans-splicing
• Are we there yet?
• Intrathecal gene transfer by adeno-associated virus for pain

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Walsh during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.